Nexgel (NXGLW) Shares Outstanding (2018 - 2025)
Nexgel's (NXGLW) quarterly Shares Outstanding (Entity) came in at $8.1 million in Q4 2025, up 6.61% YoY from $7.6 million in Q4 2024, and little changed on a QoQ basis from $8.1 million in Q3 2025.
Nexgel (NXGLW) Shares Outstanding (2018 - 2025) Analysis & Trends
Nexgel (NXGLW) has 8 years of Shares Outstanding (Entity) data on file, last reported at $8.1 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 6.61% year-over-year to $8.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.1 million (up 6.61% YoY) and the FY2025 annual result came in at $8.1 million, up 6.61% from the prior year.
- Shares Outstanding (Entity) was little changed at $8.1 million in Q4 2025, from $8.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $5.7 billion in Q2 2023 to a low of $2.9 million in Q1 2021.
- A 5-year average of $846.0 million and a median of $6.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 186938.12% — and 2023, when it plunged 99.9%.
- Tracing NXGLW's Shares Outstanding (Entity) over 5 years: stood at $3.0 million in 2021, then surged by 87.18% to $5.6 million in 2022, then rose by 2.94% to $5.7 million in 2023, then surged by 33.03% to $7.6 million in 2024, then gained by 6.61% to $8.1 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $8.1 million (Q4 2025), $8.1 million (Q3 2025), and $7.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 9.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.85 Mn |
| Sep 30, 2025 | 7.97 Mn |
| Jun 30, 2025 | 7.65 Mn |
| Mar 31, 2025 | 7.65 Mn |
| Dec 31, 2024 | 6.51 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Dec 31, 2023 | 5.67 Mn |
| Sep 30, 2023 | 5.71 Mn |
| Jun 30, 2023 | 5.66 Bn |
| Mar 31, 2023 | 5.59 Bn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 5.57 Bn |
| Jun 30, 2022 | 5.57 Mn |
| Mar 31, 2022 | 5.57 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 2.98 Mn |
| Jun 30, 2021 | 2.94 Mn |
| Mar 31, 2021 | 2.87 Mn |